Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary

Practical Radiation Oncology

Volumn 2, Issue 1, 2012, Pages 2-9

  Solberg, Timothy D ^a   Balter, James M ^b   Benedict, Stanley H ^c   Fraass, Benedick A ^d   Kavanagh, Brian ^e   Miyamoto, Curtis ^f   Pawlicki, Todd ^g   Potters, Louis ^h   Yamada, Yoshiya ⁱ  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h LONG ISLAND JEWISH MEDICAL CENTER   (United States)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL COMPETENCE; COMPUTER ASSISTED RADIOTHERAPY; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; IMAGE QUALITY; IMMOBILIZATION; MEDICAL EDUCATION; MEDICAL ERROR; MEDICAL SPECIALIST; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY; THREE DIMENSIONAL IMAGING; TOTAL QUALITY MANAGEMENT; TREATMENT PLANNING;

EID: 84155172270     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2011.06.014     Document Type: Article

References (50)

1. Larson DA, Bova FJ, Eisert D, et al. Current radiosurgery practice: results of an ASTRO survey. Task Force on Stereotactic Radiosurgery, American Society for Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 1994, 28:523-526.
2. Schell MC, Bova FJ, Larson DA, et al. AAPM Report No. 54: Stereotactic radiosurgery. Report of task group No. 42 of the American Association of Physicists in Medicine 1995, Available at:, Accessed August 10, 2011. http://www.aapm.org/pubs/reports/RPT_54.pdff.
3. ACR Practice Guideline: Practice guideline for the performance of stereotactic American. College or Radiology and American Society for Therapeutic Radiology and Oncology 2006.
4. CAPCA Quality Control Standards: Stereotactic Radiosurgery/Radiotherapy Standards for quality control at Canadian radiation treatment centres 2006, Canadian Association of Provincial Cancer Agencies (CAPCA).
5. Potters L, Kavanagh B, Galvin JM, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2010, 76:326-332.
6. Benedict SH, Yenice KM, Followill D, et al. Stereotactic Body Radiation Therapy: The Report of AAPM Task Group 101. Med Phys 2010, 37:4078-4101.
7. Radiotherapy Risk Profile Technical Manual 2006, WHO Press, Geneva, Switzerland.
8. The Royal College of Radiologists, Society and College of Radiographers, Institute of Physics and Engineering in Medicine, National Patient Safety Agency, British Institute of Radiology. Towards Safer Radiotherapy. London: The Royal College of Radiologists; 2008.
9. HTA Initiative #22: A Reference Guide for Learning from Incidents in Radiation Treatment 2006, Alberta Heritage Foundation for Medical Research, Edmonton, Alberta.
10. ICRP publication 112 A report of preventing accidental exposures from new external beam radiation therapy technologies. Ann ICRP 2009, 39:3-5.
11. Hendee WR, Herman MG Improving patient safety in radiation oncology. Pract Radiat Oncol 2011, 1:16-21.
12. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-1672.
13. Suh J Stereotactic radiosurgery for the management of brain metastases. New Engl J Med 2010, 362:1119-1127.
14. Combs SE, Welzel T, Schulz-Ertner D, Huber PE, Debus J Differences in clinical results after linac-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Int J Radiat Oncol Biol Phys 2010, 76:193-200.
15. Selch MT, Ahn E, Laskari A, et al. Stereotactic radiotherapy for treatment of cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys 2004, 59:101-111.
16. Spiegelmann R, Cohen ZR, Nissim O, Alezra D, Pfeffer R Cavernous sinus meningiomas: a large LINAC radiosurgery series. J Neurooncol 2010, 98:195-202.
17. Sheehan JP, Williams B, Yen CP Stereotactic radiosurgery for WHO grade I meningiomas. J Neurooncol 2010, 99:407-416.
18. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303:1070-1076.
19. Heron DE, Ferris RL, Karamouzis M, et al. Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial. Int J Radiat Oncol Biol Phys 2009, 75:1493-1500.
20. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009, 27:3290-3296.
21. Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009, 27:1572-1578.
22. Rusthoven KE, Kavanagh BD, Burri SH, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009, 27:1579-1584.
23. Lee MT, Kim JJ, Dinniwell R, et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009, 27:1585-1591.
24. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009, 75:677-682.
25. Baumann P, Nyman J, Hoyer M, et al. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Radiother Oncol 2008, 88:359-367.
26. King CR, Brooks JD, Gill H, Pawlicki T, Cotrutz C, Presti JC Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys 2009, 73:1043-1048.
27. Tse RV, Hawkins M, Lockwood G, et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 2008, 26:657-664.
28. Chang EL, Shiu AS, Mendel E, et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 2007, 7:151-160.
29. Milano MT, Katz AW, Muhs AG, et al. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 2008, 112:650-658.
30. Blomgren H, Lax I, Náslund I, Svanstróm R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995, 34:861-870.
31. Sawrie SM, Fiveash JB, Caudell JJ Stereotactic body radiation therapy for liver metastases and primary hepatocellular carcinoma: normal tissue tolerances and toxicity. Cancer Control 2010, 17:111-119.
32. Hoppe BS, Laser B, Kowalski AV, et al. Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?. Int J Radiat Oncol Biol Phys 2008, 72:1283-1286.
33. Bradley J Radiographic response and clinical toxicity following SBRT for stage I lung cancer. J Thorac Oncol 2007, 2(7 Suppl 3):S118-S1224.
34. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006, 24:4833-4839.
35. Borius PY, Debono B, Latorzeff I, et al. Dosimetric stereotactic radiosurgical accident: Study of 33 patients treated for brain metastases. Neurochirurgie 2010, 56:368-373. [Article in French].
36. Derreumaux S, Etard C, Huet I.C, et al. Lessons from recent accidents in radiation therapy in France. Rad Prot Dosim 2010, 131:130-135.
37. Gourmelon P, Bey E, De Revel T, et al. The French radiation accident experience: emerging concepts in radiation burn and ARS therapies and in brain radiopathology. Radioprotection 2008, 43:23-26.
38. Bogdanich W, Rebelo K. The radiation boom: A pinpoint beam strays invisibly, harming instead of healing. The New York Times (New York Edition). December 28, 2010; section A:1.
39. Leksell Gamma Knife, "New 4-mm helmet output factor.'' Elekta Bulletin 98-02-17. Feb. 17, 1998.
40. Gibbons JP, Mihailidis D, Worthington C, et al. Technical note: The effect of the 4-mm-collimator output factor on gamma knife dose distributions. J Appl Clin Med Phys 2003, 4:386-389.
41. Stahel PF, Sabel AL, Victoroff MS, et al. Wrong-site and wrong-patient procedures in the universal protocol era. Arch Surg 2010, 145:978-984.
42. ABT Associates I The ABT study of medical physicist work values for radiation oncology physics services, round III. American Association of Physicists in Medicine (AAPM) Available at:, Accessed August 10, 2010. http://www.aapm.org/pubs/reports/ABTIIIReport.pdf.
43. RTOG 0236: A phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage i/ii non-small cell lung cancer 2005, Radiation Therapy Oncology Group, Available at:, Accessed August 10, 2011. http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?action=openFile&FileID=4612.
44. RTOG 0618: A phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with operable stage i/ii non-small cell lung cancer 2007, Radiation Therapy Oncology Group, Available at:, Accessed August 10, 2011. http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?action=openFile&FileID=4650.
45. Das IJ, Cheng C-W, Watts RJ, et al. Accelerator beam data commissioning equipment and procedures: Report of the TG-106 of the Therapy Physics Committee of the AAPM. Med Phys 2010, 35:4186-4215.
46. Bjarngard BE, Tsai JS, Rice RK Doses on the central axes of narrow 6-MV x-ray beams. Med Phys 1990, 17:794-799.
47. Ding GX, Duggan DM, Coffey CW Commissioning stereotactic radiosurgery beams using both experimental and theoretical methods. Phys Med Biol 2006, 51:2549-2566.
48. Radiation in medicine: a need for regulatory reform 1996, The National Academies Press, Washington, DC. K.D. Gottfried, G. Penn (Eds.).
49. Cunningham J, Coffey M, Knóós T, Holmberg O Radiation Oncology Safety Information System (ROSIS)-profiles of participants and the first 1074 incident reports. Radiother Oncol 2010, 97:601-607.
50. Mutic S, Brame RS, Oddiraju S, et al. Event (error and near-miss) reporting and learning system f or process improvement in radiation oncology. Med Phys 2010, 37:5027-5036.